BioPorto A/S (THOXF)
USD 0.29
(0.0%)
USD 0.29
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 30.95 Million DKK | 6.87% |
| 2022 | 28.96 Million DKK | 19.44% |
| 2021 | 24.25 Million DKK | 4.53% |
| 2020 | 23.2 Million DKK | -12.84% |
| 2019 | 26.62 Million DKK | 2.33% |
| 2018 | 26.01 Million DKK | 3.42% |
| 2017 | 25.15 Million DKK | 21.4% |
| 2016 | 20.72 Million DKK | 1.65% |
| 2015 | 20.38 Million DKK | 8.97% |
| 2014 | 18.7 Million DKK | 12.52% |
| 2013 | 16.62 Million DKK | -6.9% |
| 2012 | 17.85 Million DKK | -3.91% |
| 2011 | 18.58 Million DKK | 34.65% |
| 2010 | 13.8 Million DKK | 25.38% |
| 2009 | 11 Million DKK | 31.99% |
| 2008 | 8.34 Million DKK | 0.0% |
| 2007 | 8.34 Million DKK | 50.16% |
| 2006 | 5.55 Million DKK | 27.33% |
| 2005 | 4.36 Million DKK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 9.2 Million DKK | -2.76% |
| 2024 Q1 | 9.46 Million DKK | 44.22% |
| 2023 Q2 | 7.74 Million DKK | -3.64% |
| 2023 Q4 | 6.56 Million DKK | -23.8% |
| 2023 Q3 | 8.6 Million DKK | 11.11% |
| 2023 Q1 | 8.04 Million DKK | -7.47% |
| 2023 FY | 30.95 Million DKK | 6.87% |
| 2022 Q4 | 8.69 Million DKK | 64.86% |
| 2022 FY | 28.96 Million DKK | 19.44% |
| 2022 Q1 | 6.5 Million DKK | -4.48% |
| 2022 Q2 | 8.5 Million DKK | 30.82% |
| 2022 Q3 | 5.27 Million DKK | -38.03% |
| 2021 Q4 | 6.8 Million DKK | 28.58% |
| 2021 FY | 24.25 Million DKK | 4.53% |
| 2021 Q1 | 5.57 Million DKK | -25.96% |
| 2021 Q2 | 6.57 Million DKK | 17.91% |
| 2021 Q3 | 5.29 Million DKK | -19.5% |
| 2020 Q3 | 4.74 Million DKK | -29.6% |
| 2020 Q1 | 4.19 Million DKK | -36.71% |
| 2020 FY | 23.2 Million DKK | -12.84% |
| 2020 Q2 | 6.73 Million DKK | 60.61% |
| 2020 Q4 | 7.53 Million DKK | 58.84% |
| 2019 Q2 | 7.83 Million DKK | 42.07% |
| 2019 Q4 | 6.62 Million DKK | -0.3% |
| 2019 Q3 | 6.64 Million DKK | -15.15% |
| 2019 FY | 26.62 Million DKK | 2.33% |
| 2019 Q1 | 5.51 Million DKK | -37.95% |
| 2018 Q4 | 8.88 Million DKK | 65.17% |
| 2018 FY | 26.01 Million DKK | 3.42% |
| 2018 Q1 | 4.61 Million DKK | -32.28% |
| 2018 Q2 | 7.13 Million DKK | 54.71% |
| 2018 Q3 | 5.38 Million DKK | -24.62% |
| 2017 Q1 | 5.74 Million DKK | -8.52% |
| 2017 Q4 | 6.81 Million DKK | 13.91% |
| 2017 Q3 | 5.98 Million DKK | -9.67% |
| 2017 FY | 25.15 Million DKK | 21.4% |
| 2017 Q2 | 6.62 Million DKK | 15.27% |
| 2016 Q4 | 6.27 Million DKK | 36.3% |
| 2016 FY | 20.72 Million DKK | 1.65% |
| 2016 Q1 | 5.18 Million DKK | -10.11% |
| 2016 Q2 | 4.65 Million DKK | -10.23% |
| 2016 Q3 | 4.6 Million DKK | -1.01% |
| 2015 Q1 | 4.12 Million DKK | -15.72% |
| 2015 Q3 | 4.68 Million DKK | -19.3% |
| 2015 Q4 | 5.76 Million DKK | 23.1% |
| 2015 Q2 | 5.8 Million DKK | 40.57% |
| 2015 FY | 20.38 Million DKK | 8.97% |
| 2014 Q1 | 4.75 Million DKK | 8.54% |
| 2014 FY | 18.7 Million DKK | 12.52% |
| 2014 Q3 | 4.57 Million DKK | 1.92% |
| 2014 Q4 | 4.89 Million DKK | 7.18% |
| 2014 Q2 | 4.48 Million DKK | -5.6% |
| 2013 Q1 | 3 Million DKK | -38.06% |
| 2013 FY | 16.62 Million DKK | -6.9% |
| 2013 Q3 | 4.98 Million DKK | 17.01% |
| 2013 Q4 | 4.37 Million DKK | -12.13% |
| 2013 Q2 | 4.25 Million DKK | 41.48% |
| 2012 Q4 | 4.85 Million DKK | 14.87% |
| 2012 Q2 | 3.68 Million DKK | -27.56% |
| 2012 Q1 | 5.08 Million DKK | 18.8% |
| 2012 Q3 | 4.22 Million DKK | 14.76% |
| 2012 FY | 17.85 Million DKK | -3.91% |
| 2011 Q1 | 6.41 Million DKK | 91.92% |
| 2011 Q3 | 4.17 Million DKK | 12.5% |
| 2011 Q4 | 4.28 Million DKK | 2.56% |
| 2011 FY | 18.58 Million DKK | 34.65% |
| 2011 Q2 | 3.71 Million DKK | -42.16% |
| 2010 Q2 | 3.41 Million DKK | -3.37% |
| 2010 Q4 | 3.34 Million DKK | -4.92% |
| 2010 Q3 | 3.51 Million DKK | 3.05% |
| 2010 FY | 13.8 Million DKK | 25.38% |
| 2010 Q1 | 3.53 Million DKK | 29.44% |
| 2009 Q3 | 2.65 Million DKK | -1.04% |
| 2009 Q1 | 2.94 Million DKK | 0.0% |
| 2009 FY | 11 Million DKK | 31.99% |
| 2009 Q4 | 2.72 Million DKK | 2.87% |
| 2009 Q2 | 2.68 Million DKK | -9.09% |
| 2008 FY | 8.34 Million DKK | 0.0% |
| 2007 FY | 8.34 Million DKK | 50.16% |
| 2006 FY | 5.55 Million DKK | 27.33% |
| 2005 FY | 4.36 Million DKK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Bio Medica Corporation | 913 Thousand USD | -3290.8% |
| Arrayit Corporation | 4.37 Million USD | -607.24% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 25.85 Million USD | -19.723% |
| Bioqual, Inc. | 58.59 Million USD | 47.162% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 15.29 Million USD | -102.393% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | 99.581% |
| HTG Molecular Diagnostics, Inc. | 6.36 Million USD | -386.285% |
| iMD Companies, Inc. | - USD | -Infinity% |
| IDenta Corp. | 1.05 Million USD | -2843.923% |
| Interpace Biosciences, Inc. | 40.21 Million USD | 23.017% |
| Integrative Health Technologies, Inc. | 447.49 Thousand USD | -6818.004% |
| InVitro International | 792.62 Thousand USD | -3805.741% |
| Lumos Diagnostics Holdings Limited | 11.13 Million USD | -178.124% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 7.22 Million USD | -328.53% |
| NovelStem International Corp. | 12 Thousand USD | -257883.333% |
| Optigenex Inc. | 465.97 Thousand USD | -6543.775% |
| PharmChem, Inc. | 6.01 Million USD | -414.902% |
| Proteome Sciences plc | 6.4 Million USD | -383.67% |
| Response Genetics, Inc | 18.04 Million USD | -71.608% |
| Rennova Health, Inc. | 13.03 Million USD | -137.478% |
| RushNet, Inc. | 1.78 Million USD | -1631.548% |
| ScreenPro Security Inc. | 1.91 Million USD | -1517.363% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 3.79 Million USD | -715.741% |
| Todos Medical Ltd. | 7.69 Million USD | -302.313% |